Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Rueda

Showing results (81-90 of 182) with videos related to

Pageof 19
Sort By:
Frontiers in Oncology|February 10, 2022
Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in SpainVirginia Arrazubi, Gerardo Cajaraville, David Cantero, et al.
Plastic and Reconstructive Surgery. Global Open|April 8, 2026
Effectiveness of the Implementation of a Bundle Protocol for the Reduction of Postmastectomy Reconstruction FailuresCeleste M Guillén Rodríguez, Alberto Jiménez Puente, Francisco Rivas Ruiz, et al.
Haematologica|September 23, 2017
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase studyPieternella Lugtenburg, Irit Avivi, Henriette Berenschot, et al.
Oncology Letters|December 1, 2016
Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five casesJulia Alcaide, Mayte Delgado, Marta Legerén, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2025
SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025)Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, et al.
Medicina Clinica|May 23, 2025
Prognostic value of extreme NT-proBNP levels in patients hospitalized for heart failureMiguel Yebra Yebra, Alejandro Sáenz de Urturi Rodríguez, Sergio González García, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 8, 2023
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, et al.
European Urology Open Science|November 17, 2022
Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysisTasmania Del Pino-Sedeño, Diego Infante-Ventura, Aythami de Armas Castellano, et al.
Journal of Clinical Medicine|February 27, 2026
Association of <i>IL7</i> rs16906115 Polymorphism with Immune-Related Adverse Events in Patients with Advanced Lung Cancer Undergoing ImmunotherapyAndrea González-Hernández, Guillermo Paz-López, Beatriz Martínez-Gálvez, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2003
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancerJuan José Reina, Jorge Aparicio, Javier Salvador, et al.
Pageof 19

Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
Frontiers in Oncology|February 10, 2022
Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in SpainVirginia Arrazubi, Gerardo Cajaraville, David Cantero, et al.
Plastic and Reconstructive Surgery. Global Open|April 8, 2026
Effectiveness of the Implementation of a Bundle Protocol for the Reduction of Postmastectomy Reconstruction FailuresCeleste M Guillén Rodríguez, Alberto Jiménez Puente, Francisco Rivas Ruiz, et al.
Haematologica|September 23, 2017
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase studyPieternella Lugtenburg, Irit Avivi, Henriette Berenschot, et al.
Oncology Letters|December 1, 2016
Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five casesJulia Alcaide, Mayte Delgado, Marta Legerén, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2025
SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025)Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, et al.
Medicina Clinica|May 23, 2025
Prognostic value of extreme NT-proBNP levels in patients hospitalized for heart failureMiguel Yebra Yebra, Alejandro Sáenz de Urturi Rodríguez, Sergio González García, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 8, 2023
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez, et al.
European Urology Open Science|November 17, 2022
Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysisTasmania Del Pino-Sedeño, Diego Infante-Ventura, Aythami de Armas Castellano, et al.
Journal of Clinical Medicine|February 27, 2026
Association of <i>IL7</i> rs16906115 Polymorphism with Immune-Related Adverse Events in Patients with Advanced Lung Cancer Undergoing ImmunotherapyAndrea González-Hernández, Guillermo Paz-López, Beatriz Martínez-Gálvez, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2003
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancerJuan José Reina, Jorge Aparicio, Javier Salvador, et al.
Pageof 19